Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Apr 19, 2026; 16(4): 117493
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.117493
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.117493
Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease
Qun-Shan Lu, Lin Ma, Wen-Jing Jiang, Xing-Bang Wang, Mei Lu, Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Lin Ma, Wen-Jing Jiang, Xing-Bang Wang, Mei Lu, Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Author contributions: Lu QS and Lu M designed the study; Lu QS, Ma L, Jiang WJ, and Wang XB performed the experiments; Lu QS and Lu M wrote the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Mei Lu, MD, Professor, Department of Geriatric Medicine, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan 250012, Shandong Province, China. lumei@qiluhospital.com
Received: December 9, 2025
Revised: December 15, 2025
Accepted: January 23, 2026
Published online: April 19, 2026
Processing time: 111 Days and 23.6 Hours
Revised: December 15, 2025
Accepted: January 23, 2026
Published online: April 19, 2026
Processing time: 111 Days and 23.6 Hours
Core Tip
Core Tip: This manuscript serves as an official erratum to correct an error in Figure 3B of the article “Lu QS, Ma L, Jiang WJ, Wang XB, Lu M. KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ame